Startseite Relationship between 25(OH)D levels and circulating lipids in African American adolescents
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Relationship between 25(OH)D levels and circulating lipids in African American adolescents

  • Swetha Sriram , Ivana Croghan , Aida Lteif , Bonnie Donelan-Dunlap , Zhuo Li und Seema Kumar EMAIL logo
Veröffentlicht/Copyright: 22. September 2016

Abstract

Background:

Vitamin D deficiency is commonly seen among African American adolescents. Lipid levels during childhood are excellent predictors of adult dyslipidemia and atherosclerosis. There is a paucity of data on the relationship between 25 hydroxy vitamin D [25(OH)D] levels and lipids among African American adolescents. The objective of this study was to determine if there is an association between 25(OH)D levels and circulating lipids in African American adolescents residing in midwestern United States.

Methods:

African American adolescents residing in Rochester, MN (latitude 44°N), USA, underwent measurements of 25(OH)D and lipids following overnight fast. Pearson’s correlation test, linear regression model and scatter plots were used to explore the association between 25(OH)D levels and lipids.

Results:

25(OH)D levels <30 ng/mL were seen in 21/24 (87%) of the subjects. 25(OH)D levels were inversely correlated with total cholesterol (r=–0.42; p=0.040) and with non-high-density lipoprotein (non-HDL) cholesterol (r=–0.42; p=0.040 ). These associations remained statistically significant after adjustment for age, gender and adiposity. In the multivariate linear regression model, and after adjusting for BMI Z-score, each 1 ng/mL increase in 25(OH)D was associated with a decrease in total cholesterol of 1.38 mg/dL (95% CI: –2.63, –0.14, p=0.030) and with a decrease in non-HDL cholesterol of 1.14 mg/dL (95% CI: –2.09, –0.18, p=0.020).

Conclusions:

25(OH)D levels were inversely correlated with total cholesterol and non-HDL cholesterol levels in African American adolescents residing in midwestern United States. Further studies with larger sample sizes are needed to determine if low vitamin D status in African American adolescents is a potential modifiable risk factor for cardiovascular disease.


Corresponding author: Seema Kumar, MD, Division of Pediatric Endocrinology, Department of Pediatric and Adolescent Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN-55905, USA

  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: This work was funded by a grant from The Office of Health Disparities Research at Mayo Clinic College of Medicine.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Lloyd-Jones D, Adams RJ, Brown TM, Carnethon M, Dai S, et al. Executive summary: heart disease and stroke statistics–2010 update: a report from the American Heart Association. Circulation 2010;121:948–54.10.1161/CIRCULATIONAHA.109.192666Suche in Google Scholar PubMed

2. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: summary report. Pediatrics 2011;128(Suppl 5):S213–56.10.1542/peds.2009-2107CSuche in Google Scholar PubMed PubMed Central

3. Rainwater DL, McMahan CA, Malcom GT, Scheer WD, Roheim PS, et al. Lipid and apolipoprotein predictors of atherosclerosis in youth: apolipoprotein concentrations do not materially improve prediction of arterial lesions in PDAY subjects. The PDAY Research Group. Arterioscler Thromb Vasc Biol 1999;19:753–61.10.1161/01.ATV.19.3.753Suche in Google Scholar

4. Frontini MG, Srinivasan SR, Xu JH, Tang R, Bond MG, et al. Utility of non-high-density lipoprotein cholesterol versus other lipoprotein measures in detecting subclinical atherosclerosis in young adults (The Bogalusa Heart Study). Am J Cardiol 2007;100:64–8.10.1016/j.amjcard.2007.01.071Suche in Google Scholar PubMed

5. Srinivasan SR, Frontini MG, Xu J, Berenson GS. Utility of childhood non-high-density lipoprotein cholesterol levels in predicting adult dyslipidemia and other cardiovascular risks: the Bogalusa Heart Study. Pediatrics 2006;118:201–6.10.1542/peds.2005-1856Suche in Google Scholar PubMed

6. Warnick GR, Nakajima K. Fasting versus nonfasting triglycerides: implications for laboratory measurements. Clin Chem 2008;54:14–6.10.1373/clinchem.2007.098863Suche in Google Scholar PubMed

7. Weisberg P, Scanlon KS, Li R, Cogswell ME. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr 2004;80(6 Suppl):1697S–705S.10.1093/ajcn/80.6.1697SSuche in Google Scholar PubMed

8. McAllister JC, Lane AT, Buckingham BA. Vitamin D deficiency in the San Francisco Bay Area. J Pediatr Endocrinol Metab 2006;19:205–8.10.1515/JPEM.2006.19.3.205Suche in Google Scholar PubMed

9. Rosen CJ, Abrams SA, Aloia JF, Brannon PM, Clinton SK, et al. IOM committee members respond to endocrine society vitamin D guideline. J Clin Endocrinol Metab 2012;97:1146–52.10.1210/jc.2011-2218Suche in Google Scholar PubMed PubMed Central

10. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911–30.10.1210/jc.2011-0385Suche in Google Scholar PubMed

11. Holick MF. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006;81:353–73.10.4065/81.3.353Suche in Google Scholar

12. Malabanan A, Veronikis IE, Holick MF. Redefining vitamin D insufficiency. Lancet 1998;351:805–6.10.1016/S0140-6736(05)78933-9Suche in Google Scholar

13. Bischof MG, Heinze G, Vierhapper H. Vitamin D status and its relation to age and body mass index. Horm Res 2006;66:211–5.10.1159/000094932Suche in Google Scholar PubMed

14. Thomas MK, Lloyd-Jones DM, Thadhani RI, Shaw AC, Deraska DJ, et al. Hypovitaminosis D in medical inpatients. N Engl J Med 1998;338:777–83.10.1056/NEJM199803193381201Suche in Google Scholar PubMed

15. Mansbach JM, Ginde AA, Camargo CA, Jr. Serum 25-hydroxyvitamin D levels among US children aged 1 to 11 years: do children need more vitamin D? Pediatrics 2009;124:1404–10.10.1542/peds.2008-2041Suche in Google Scholar PubMed PubMed Central

16. Saintonge S, Bang H, Gerber LM. Implications of a new definition of vitamin D deficiency in a multiracial us adolescent population: the National Health and Nutrition Examination Survey III. Pediatrics 2009;123:797–803.10.1542/peds.2008-1195Suche in Google Scholar PubMed

17. Gordon CM, Feldman HA, Sinclair L, Williams AL, Kleinman PK, et al. Prevalence of vitamin D deficiency among healthy infants and toddlers. Arch Pediatr Adolesc Med 2008;162:505–12.10.1001/archpedi.162.6.505Suche in Google Scholar PubMed PubMed Central

18. Rajakumar K, Holick MF, Jeong K, Moore CG, Chen TC, et al. Impact of season and diet on vitamin D status of African American and Caucasian children. Clin Pediatr (Phila) 2011;50:493–502.10.1177/0009922810397334Suche in Google Scholar PubMed PubMed Central

19. Gordon CM, DePeter KC, Feldman HA, Grace E, Emans SJ. Prevalence of vitamin D deficiency among healthy adolescents. Arch Pediatr Adolesc Med 2004;158:531–7.10.1001/archpedi.158.6.531Suche in Google Scholar PubMed

20. Cole CR, Grant FK, Tangpricha V, Swaby-Ellis ED, Smith JL, et al. 25-hydroxyvitamin D status of healthy, low-income, minority children in Atlanta, Georgia. Pediatrics 2010;125:633–9.10.1542/peds.2009-1928Suche in Google Scholar PubMed PubMed Central

21. Norman PE, Powell JT. Vitamin D and cardiovascular disease. Circ Res 2014;114:379–93.10.1161/CIRCRESAHA.113.301241Suche in Google Scholar PubMed

22. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 2009;124: e362–70.10.1542/peds.2009-0051Suche in Google Scholar PubMed PubMed Central

23. Johnson MD, Nader NS, Weaver AL, Singh R, Kumar S. Relationships between 25-hydroxyvitamin D levels and plasma glucose and lipid levels in pediatric outpatients. J Pediatr 2010;156:444–9.10.1016/j.jpeds.2009.09.070Suche in Google Scholar PubMed

24. Williams DM, Fraser A, Sayers A, Fraser WD, Hingorani A, et al. Associations of 25-hydroxyvitamin D2 and D3 with cardiovascular risk factors in childhood: cross-sectional findings from the Avon Longitudinal Study of Parents and Children. J Clin Endocrinol Metab 2012;97:1563–71.10.1210/jc.2011-2335Suche in Google Scholar PubMed PubMed Central

25. Rajakumar K, de las Heras J, Chen TC, Lee S, Holick MF, et al. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab 2011;96:1560–7.10.1210/jc.2010-2388Suche in Google Scholar PubMed PubMed Central

26. Ashraf A, Alvarez J, Saenz K, Gower B, McCormick K, et al. Threshold for effects of vitamin D deficiency on glucose metabolism in obese female African-American adolescents. J Clin Endocrinol Metab 2009;94:3200–6.10.1210/jc.2009-0445Suche in Google Scholar PubMed PubMed Central

27. Kuczmarski RJ, Ogden CL, Guo SS, Grummer-Strawn LM, Flegal KM, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11 2002;246:1–190.Suche in Google Scholar

28. Birken CS, Lebovic G, Anderson LN, McCrindle BW, Mamdani M, et al. Association between vitamin D and circulating lipids in early childhood. PLoS One 2015;10:e0131938.10.1371/journal.pone.0131938Suche in Google Scholar PubMed PubMed Central

29. Ashraf AP, Alvarez JA, Gower BA, Saenz KH, McCormick KL. Associations of serum 25-hydroxyvitamin D and components of the metabolic syndrome in obese adolescent females. Obesity (Silver Spring) 2011;19:2214–21.10.1038/oby.2011.110Suche in Google Scholar PubMed PubMed Central

30. Wood AD. Secombes KR, Thies F, Aucott L, Black AJ, et al. Vitamin D3 supplementation has no effect on conventional cardiovascular riks factors: a parallel-group, doube-lind, placebo controlled RCT. J Clin Endocrinol Metab 2012; 97:3557–68.10.1210/jc.2012-2126Suche in Google Scholar PubMed

31. Jorde R, Snebe M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010: 267:462–72.10.1111/j.1365-2796.2009.02181.xSuche in Google Scholar PubMed

32. Wang H, Xia N, Tang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomzied clinical trials. Lipids Health Dis 2012;11:42.10.1186/1476-511X-11-42Suche in Google Scholar PubMed PubMed Central

33. Nader NS, Aguirre Castaneda R, Wallace J, Singh R, Weaver A, et al. Effect of vitamin D3 supplementation on seum 25(OH)D, lipids or markers of insulin resistance in obese adolescents: a prospective, randomized, placebo controlled pilot trial. Horm Res Pediatr 2014;82:107–12.10.1159/000362449Suche in Google Scholar PubMed

34. Javed A, Vella A, Balagopal PB, Fischer PR, Piccini F, et al. Cholecalciferol supplementation does not influence β cell function and insulin action in obese adolescents: a prospective double blind randomized trial. J Nutr 2015;145: 284–90.10.3945/jn.114.202010Suche in Google Scholar PubMed PubMed Central

35. Shah S, Wilson DM, Bahrach LK. Large doses of vitamin D fail to increase 25-hydroxyvitamin D levels or to alter cardiovascular risk factors in obese adolescents: a pliot study. J Adolesc Health 2015;57:19–23.10.1016/j.jadohealth.2015.02.006Suche in Google Scholar PubMed

36. Gonzalez FJ, Moschetta A. Potential role of the vitamin D receptor in control of cholesterol levels. Gastroenterology 2014;146:899–902.10.1053/j.gastro.2014.02.022Suche in Google Scholar PubMed PubMed Central

37. Jiang W, Miyamoto T, Kakizawa T, Nishio SI, Oiwa A, et al. Inhibition of LXRalpha signaling by vitamin D receptor: possible role of VDR in bile acid synthesis. Biochem Biophys Res Commun 2006;351:176–84.10.1016/j.bbrc.2006.10.027Suche in Google Scholar PubMed

38. Honjo Y, Sasaki S, Kobayashi Y, Misawa H, Nakamura H. 1,25-dihydroxyvitamin D3 and its receptor inhibit the chenodeoxycholic acid-dependent transactivation by farnesoid X receptor. J Endocrinol 2006;188:635–43.10.1677/joe.1.06105Suche in Google Scholar PubMed

39. de la Hunty A, Wallace AM, Gibson S, Viljakainen H, Lamberg-Allardt C, et al. UK Food Standards Agency Workshop Consensus Report: the choice of method for measuring 25-hydroxyvitamin D to estimate vitamin D status for the UK National Diet and Nutrition Survey. Br J Nutr 2010;104:612–9.10.1017/S000711451000214XSuche in Google Scholar PubMed

Received: 2016-3-9
Accepted: 2016-8-1
Published Online: 2016-9-22
Published in Print: 2016-10-1

©2016 Walter de Gruyter GmbH, Berlin/Boston

Artikel in diesem Heft

  1. Frontmatter
  2. Review
  3. An update on thyroid-associated ophthalmopathy in children and adolescents
  4. Mini Review
  5. Systematic review and meta-analysis of the association between mumps during childhood and risk of type 1 diabetes mellitus
  6. Original Articles
  7. Glycemic variability predicts inflammation in adolescents with type 1 diabetes
  8. Prevalence and risk factors for diabetic retinopathy in a hospital-based population of Australian children and adolescents with type 1 diabetes
  9. One month of omega-3 fatty acid supplementation improves lipid profiles, glucose levels and blood pressure in overweight schoolchildren with metabolic syndrome
  10. The outcome of seven patients with hereditary tyrosinemia type 1
  11. Increased oxidative stress parameters in children with moderate iodine deficiency
  12. Relationship between 25(OH)D levels and circulating lipids in African American adolescents
  13. Endoglin and obestatin levels, cardiometabolic risk factors and subclinical atherosclerosis in children aged 10–18 years
  14. Lipoprotein-associated phospholipase A2 activity and low-density lipoprotein subfractions after a 2-year treatment with atorvastatin in adolescents with type 1 diabetes
  15. Genetic characteristics and long-term follow-up of 11 patients with congenital hyperinsulinism followed in a single center
  16. Pituitary volume in children with growth hormone deficiency, idiopathic short stature and controls
  17. Case Reports
  18. A novel insulin receptor mutation in an adolescent with acanthosis nigricans and hyperandrogenism
  19. Primary hyperparathyroidism may masquerade as rickets-osteomalacia in vitamin D replete children
  20. Co-existence of phenylketonuria either with maple syrup urine disease or Sandhoff disease in two patients from Iran: emphasizing the role of consanguinity
  21. Severe malnutrition causing superior mesenteric artery syndrome in an adolescent with Triple A syndrome
  22. Solving a case of allelic dropout in the GNPTAB gene: implications in the molecular diagnosis of mucolipidosis type III alpha/beta
Heruntergeladen am 1.10.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2016-0090/html
Button zum nach oben scrollen